Elevance Health Inc.ELVNYSE
LOADING
|||
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-31.78%
↓ 196% below average
Average (39q)
33.13%
Historical baseline
Range
High:422.25%
Low:-90.25%
CAGR
-2.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -31.78% |
| Q2 2025 | -20.16% |
| Q1 2025 | 422.25% |
| Q4 2024 | -58.86% |
| Q3 2024 | -55.83% |
| Q2 2024 | 2.40% |
| Q1 2024 | 162.38% |
| Q4 2023 | -33.59% |
| Q3 2023 | -30.44% |
| Q2 2023 | -6.84% |
| Q1 2023 | 109.59% |
| Q4 2022 | -40.80% |
| Q3 2022 | -2.08% |
| Q2 2022 | -8.50% |
| Q1 2022 | 57.34% |
| Q4 2021 | -24.65% |
| Q3 2021 | -15.84% |
| Q2 2021 | 7.69% |
| Q1 2021 | 202.18% |
| Q4 2020 | 148.20% |
| Q3 2020 | -90.25% |
| Q2 2020 | 49.44% |
| Q1 2020 | 63.06% |
| Q4 2019 | -21.05% |
| Q3 2019 | 3.86% |
| Q2 2019 | -26.56% |
| Q1 2019 | 264.94% |
| Q4 2018 | -55.73% |
| Q3 2018 | -8.92% |
| Q2 2018 | -19.66% |
| Q1 2018 | 6.61% |
| Q4 2017 | 64.75% |
| Q3 2017 | -12.66% |
| Q2 2017 | -15.31% |
| Q1 2017 | 174.13% |
| Q4 2016 | -40.37% |
| Q3 2016 | -20.86% |
| Q2 2016 | 11.04% |
| Q1 2016 | 288.61% |
| Q4 2015 | -72.37% |